The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies

The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies

Invasive fungal diseases (IFD) remain a major cause of morbidity and mortality in hematological patients, especially those undergoing hematopoietic stem cell transplantation (HSCT). Despite relatively high incidence, diagnosis and treatment remain a challenge due to non-specific manifestation and li...

Full description

Bibliographic Details
Main Authors: Justinas Daraskevicius, Vidmantas Petraitis, Linas Davainis, Andrius Zucenka
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Fungi
Subjects:
ibrexafungerp
fungal infections
hematological malignancies
Online Access:https://www.mdpi.com/2309-608X/8/5/440

Internet

https://www.mdpi.com/2309-608X/8/5/440

Similar Items